NANOCULTURE

Delivered to
The
Chicago Literary Club
March 1, 1999

Copyright 1999 by William H. Beauman

The research for this paper led me to reread one of my all-time favorite science fiction novels, Macroscope, by Piers Anthony. It was set in the not-too-distant future after a group of super-children, endowed by genetic engineering with the most enhanced and idealized genomes imaginable, reached adulthood and began their life's work. There were a couple hundred of them, and they were reared together in a research community by professional "parents." They were all of mixed race (that is, literally mixed in the test tube-all should benefit from "hybrid vigor," a genetic attribute that is the opposite of "inbred weakness") ("We're considered non-white," one of them told a new acquaintance), and all had non-gender-identified names such as Spruce or Agate. One of the surprises that emerged from the great experiment as the children grew up was that there were not nearly as many super-geniuses as expected, considering the efforts that had been expended in that direction. In fact, many of them seemed to be downright ordinary, and they were a disappointment to their creators.

But there certainly were some super-geniuses, and the star of the group, Brad, had invented the Macroscope, a super-telescope mounted in a space station that could produce views of planets in distant galaxies as distinct and detailed as if one were simply looking out the window. The story began with one of the "ordinary" super-children, Ivo, a "reject" who had been bounced back into the ordinary world, making his way from rural Georgia to the nearest spaceport, to fly up to the Macroscope to answer a call for help. Ivo was an enthusiast of the poetry of Sidney Lanier, who lived and wrote near there, and the narrative is full of references to and quotes from his long poem, "Symphony," and from my most beloved poem of all, "The Marshes of Glynn."

"Glooms of the live-oak, beautiful-braided and woven
With intricate shades of the vines that myriad-cloven
Clamber the forks of the multiform boughs,--
Emerald twilights,--
Virginal shy lights,
Wrought of the leaves to allure to the whisper of vows,
When lovers pace timidly down through the green colonnades
Of the dim sweet woods, of the dear dark woods,
Of the heavenly woods and glades,
That run to the radiant marginal sand-beach within
The wide sea-marshes of Glynn;--"

Oh, what gorgeous language! Of course, this immediately endeared the book to me, but it is the science described in Macroscope that makes it a great sci-fi story.

The call for help that Ivo was answering was for his famous brother, the Macroscope inventor. In their survey of the universe with their new toy, the scientists had encountered a sort of galactic encyclopedia being broadcast into space. It was a fabulous opportunity to learn, but the broadcast was protected by a "mental trap" program that burned out people's minds whenever they tried to tap into it. It was based on seductive logic, so that the smarter one was, the more easily one was ensnared. Of course, the geniuses were the first to go, starting with the super-genius who started it all. Poor Brad had been turned into a vege-table, and it was hoped that Ivo, his closest childhood friend, might be some help. While Ivo was on the Macroscope space station there was political unrest there and on Earth, leading to an insurrection of the scientists, and ending in a bizarre chess tournament with the Macroscope itself as the prize. Ivo's real genius turned out to be chess, so he won, and the other scientists helped him and a small group of friends "liberate" the Macroscope, to keep it from the politicians and generals, and they started off on the most fantastic picaresque adventure story I have ever read.

One of their number-a "lowly housewife" with no scientific training-was able to get past the mind-numbing guard program and copy detailed instructions for the assembly of extraordinary machines-nano-technology. She and her husband, an engineer, spent a full year building the first machine, and another year for the next two, but after that, those machines made other machines and so on that could do nearly anything, from sealing a leaking window to terraforming a dead planet. But first came the months of tedious micro-manipulation to build tiny circuits and engines on an atomic scale.

We have been doing that in the real world for about a decade now. It started when IBM scientists reproduced their company's logo in individual silicon atoms, manually pushed into place with a scanning, tunneling atomic force microscope operating in reverse. The atomic force microscope is completely different from any light microscope or electron microscope, because it does not focus anything. It is almost entirely mechanical. Think of a tiny record turntable with a tone arm ending in a needle attached to a flexible beam cantilevered from the tip. Remember how delicately one had to lower the needle onto the record, and how the tone arm had to be perfectly counter-balanced, to keep the pressure of the needle very lightly in the groove. The atomic force microscope is very much like that, except that, instead of a diamond-tipped needle at the end, there is a long, tapering electrode made of pure silicon or a metal, drawn out to the ultimate thinness-a tip with a diameter of only a few atoms. When it is electri-fied, the charge on the tip can sense the electrical field of individual atoms. The tip is played back and forth across the flat surface of a perfect crystal, much like a phonograph needle that eventually traverses the entire surface of a record, and wherever there is a "bump"-an atom sticking up above the others-the electro-magnetic signal is recorded. Thus have the shapes of single molecules been confirmed. Operating in reverse, the electrified tip is used to nudge atoms here and there, one at a time, at will. It is crude and awkward now, analogous to nudging individual grains of sand with a telephone pole sharpened to a pencil-point, but hardly a week goes by without the announcement of another advance in the fabrication of molecular wires, tubes, even motors on the nano-scale.

"Nano-" is a prefix meaning "one-billionth," and a nanometer (nm) is the size of individual, small molecules. Just one more power of ten smaller brings us to Angstroms, the size of single atoms. Until the present decade, the smallest features that could be made in manufactured objects such as computer chips were about one-quarter of a micron, or 250 nm in size. Then came the discovery of buckminsterfullerenes, a new form of pure carbon found in the soot from carbon arcs, named after the inventor of geodesic domes, which they resemble. The smallest fullerene, or "buckyball," as they are affectionately called, is C60, a sphere of carbon atoms arranged in the pattern seen on a soccer ball. It has a diameter of 30 nm, but there is a whole family of them, and they nest one inside another like Russian dolls or the layers of an onion. It is also possible to make hemispheres and long fullerene nano-tubes with diameters from less than 2 to more than 200 nm and lengths up to 5,000 nm or 5 microns, all of which nest together readily. They are the strongest fibers known, and some believe they are the strongest fibers of any kind that are theoretically possible to make. The balls and tubes can be filled with metals, creating tiny wires and other structures that can be used to build things.

All this is the realm of physicists, but now, here come the chemists. They have discovered that one can use solutions of metals like silver nitrate or gold chloride, let the metal ions adsorb onto the surface of dissolved polymers, and then chemically reduce them to the metallic form as a coating on the outer surface of the polymer molecules. And it turns out that the polymers that are easiest to control are biopolymers such as the myosin protein in muscle fibers, and especially DNA molecules. Thus, one can make a gold wire the length and diameter of the microfibrils inside individual cells, like those of the "spindle" that orients the chromosomes in the center and then pulls them toward opposite poles during cell division.

Finally, biochemists and molecular biologists are getting into the picture by having living cells do the fabrication for them. It turns out that the best molecular motor has already been made by Mother Nature: the biochemical motors that make cilia move, and which power sperm on their epic quest. Each molecular motor is comprised of three pairs of protein molecules arranged in the shape of a hexagon, with a seventh molecule protruding from the center like an axle attached to a wheel. A young post-doc from the University of Tokyo showed just last year that each pair of base proteins causes the "axle" protein to rotate one-third of a circle, or 120 degrees, when powered by one molecule of adenosine tri-phosphate, or ATP, the energy "currency" of living cells. Best of all, the protein motor operates with nearly 100% efficiency, and the whole apparatus is only about 10 nm in diameter. Now there's a motor one could do something with!

This biological connection is one that Piers Anthony failed to predict in Macroscope. Maybe somebody will eventually succeed in making nano-machines the hard way, with physical mechanics, but it is clear to me that "nanoculture" in the test tubes and flasks of molecular biology laboratories will take the big steps much more quickly.

This thought has occurred to the barons of commerce, too. Two extra-ordinary global business trends have begun to take shape in just this decade. The first one involves the Human Genome Project, which is the gargantuan, international effort to map out the entire two-billion DNA base-pair sequence of the 100,000-gene complement of all 23 human chromosomes-the "Book of Man." The official effort is headed by Dr. James Watson of the Watson Crick team that first determined the chemical nature and structure of DNA. Watson's group has been at it for about five years already and has completed nearly half of the job. The idea was that there would be only one human genome project, every-one would share the information openly, and there would be no patenting of special genes or sequences. That ideal lasted for only a very short time, when first one, then another, then a third commercial group announced plans to do it on their own-faster and cheaper than the government's plan. Now at least half a dozen research groups, from California to Scotland to Indonesia, are racing to patent their findings. Even Watson's team has announced changes in approach, and there are new signs they may join with the cowboys from the private sector. It is significant that the fastest-growing laboratory equipment type this year and last year has been gene and protein sequencing equipment-the private company that first broke from the pack and announced plans to do it all by themselves is the major manufacturer of that equipment. It is now certain that the Book of Man will be finished within two years, before the close of 2001, and that is astounding. Meanwhile, other genome projects have been started: the "Book of Drosophila melanogaster," the common fruit fly that has been the workhorse of geneticists for generations, is already about half finished; and the "Book of Caenorhabditis elegans," a nematode worm that has become the darling of developmental biologists, who have traced the origin and fate of every one of its exactly 1006 cells, is finished already. Ditto for the "Book of E. coli," the intestinal bacterium that is most used in biotechnology, which qualifies it as the most studied life form of all. The complete genomes of more than 20 pathogenic bacteria, viruses, and protozoa have already been finished by the first splinter group, in addition to their work on the human genome, and they will complete another 50 before the end of this year! Other groups have important food crops already in the works, including corn, rice, and wheat, with literally thousands more in the information pipeline. It is an absolutely awesome undertaking, a mad scramble beyond anything ever seen before in the history of science-greater than the quest for a cure for cancer or AIDS or even the Manhattan Project. This headlong attack reminds me of another passage in "The Marshes of Glynn," because the person in the poem behaves in exactly the opposite way:

"To the edge of the wood I am drawn, I am drawn,
Where the gray beach glimmering runs, as a belt of the dawn,
For a mete and a mark
To the forest dark:--
So:
Affable live-oak, leaning low,--
Thus-with your favor-soft, with a reverent hand,
(Not lightly touching your person, Lord of the land!)
Bending your beauty aside, with a step I stand
On the firm-packed sand,
Free
By a world of marsh that borders a world of sea.
Sinuous southward and sinuous northward the shimmering band
Of the sand-beach fastens the fringe of the marsh to the folds of the land.
Inward and outward to northward and southward the beachlines linger
and curl
As a silver-wrought garment that clings to and follows the firm sweet limbs
of a girl.
Vanishing, swerving, evermore curving again into sight,
Softly the sand-beach wavers away to a dim gray looping of light
."

I suppose there is no hope of ever getting the great, greedy chemical and pharmaceutical companies to exhibit a similar reverence for nature

The other new global business trend is nothing less than the wholesale restructuring of the entire chemical industry. One after another, the behemoth, multi-national chemical companies are getting rid of their core businesses and buying into the biotechnology industries. Imperial Chemical Industries (ICI) started it all in 1993, when it split off its huge petroleum holdings and merged operations to form the biochemical specialty firm, Zeneca. Now ICI is all agri-cultural chemicals and pharmaceuticals. Shortly thereafter, Ciba-Geigy and Sandoz both sold their standard chemical businesses to specialty companies and combined the remainder to form the giant life sciences corporation, Novartis, with $13 billion invested in health care, $6 billion in agribusiness and $3 billion in nutrition business. Starting two years ago, Monsanto shed its basic chemicals and bought $6.5 billion worth of agricultural biotechnology expertise. Now, Hoechst and Rhone-Poulenc have both dumped their core chemical businesses and invested $12 billion and $7 billion, respectively, into drugs and agribusiness companies. And DuPont, after buying a huge petroleum producer even larger than themselves, has just gotten rid of it and spent $6 billion to enhance its life sciences portfolio. Of all the world's giant chemical companies, only Dow, Bayer and BASF have retained their core chemical businesses and moderated their biotechnology acquisitions somewhat. Jurgen Dormann, Hoechst's chairman, explained it this way: "Concentrating on life sciences means a shift from cyclical, high-volume, low-margin products to stable, low-volume, high margin products and from a high asset base and low R&D investment to a small asset base and high R&D investment-in other words, from bricks to brains." Gary Pfeiffer, Chief Financial Officer at DuPont, says he considers the present potential in the life sciences to be greater than that of polymer chemistry when that discipline was young nearly a century ago. Wow! I wonder what the next "Nylon" will be?

And what do these two trends mean? They mean the world of commerce is changing fundamentally. The dozen or so biotechnology companies that started up on their own in the previous decade have been gobbled up, even though most of them have yet to show a profit, just because of the head start their expertise promises to whoever owns them. And what promise! Genetic engineering and biotechnology will revolutionize agriculture, materials science, pharmaceuticals, and, most of all, medicine. Already, "pharmaceuticals" is being spelled with an "f", and "farming" is being spelled with a "ph." Human insulin is already being produced by "pharm" animals, and the vaccine for hepatitis B comes from bacterial cultures. Before long, people will get vaccinations against the rota-viruses in polluted water, which cause infant diarrhea and kill more people than any other disease, simply by eating a genetically engineered potato or apple. Milk from genetically engineered cows will carry antibodies against several diseases at once. Critical food crops are already being bio-engineered to produce their own insecticides. I don't mean dangerously toxic synthetic pesti-cides like DDT, but bio-toxins such as that produced by Bacillus thuringiensis, or "BT" bacteria, which protects all sorts of crops, from tomatoes to cotton to spruce trees, but is harmless to all creatures like us with a backbone. Now, rather than having to spray the crops with the bacterial culture, the bacterial gene that codes for the toxin is simply inserted into the genome of the crop, so that the cotton plants make their own BT toxin. There is already a third-world back-lash against the agrochemical companies and their tactic of genetically sabotaging the protected crops' seed production, so that everybody has to buy new seeds every year. They don't miss a trick, do they-it may be heartless, but it is good business.

As important as the bio-technology nanoculture will be for agriculture, I believe its effects on human genetics and human medicine will affect the lives of our friends and families even more. Let's talk about genetics first. Dean Hamer, the scientist at the National Institutes of Health in Bethesda, MD, who wrote a book on the locus of the "gay gene" on the X-chromosome a few years ago, published a fascinating book last year, Living With Our Genes, in which he explains "why they matter more than you think." It is now certain that genes determine much more than physical structures-they govern feelings, attitudes, preferences in a most fundamental way. Whether one is shy or outgoing, glum or happy with life, a risk-taker who jumps off bridges with a Bungee cord attached or one who curls up with a book, whether or not one angers easily or succumbs to addiction, all are genetically determined. My favorite example of the genetic imperative is the story of two identical twin boys separated at birth. Thirty years later, they met for the first time and were amazed to find how similar their lives were. They resembled each other, of course, but they also had similar haircuts and mustaches, and both preferred the color blue. They had similar jobs-one drove a fire-truck; the other drove an ambulance. They had nearly identical cars-big 4-wheel-drive, off-road monsters (blue, of course) with oversize tires. Both had big dogs, the same arsenal of guns, the same penchant for hunting. Both even had diminutive, strawberry-blonde wives named Marge! Well, sure, some of that has to be coincidence .

It is already possible for couples to cull through several embryos at an in vitro fertilization clinic and select the one with the fewest genetic flaws for gestation. Single cells can be removed from an embryo up to the blastula stage (in which there are from eight to a couple hundred cells) and the DNA assayed for about 75 genetic conditions today, but shortly after the Human Genome Project is completed there will be hundreds, perhaps thousands of characteristics that are amenable to analysis. By then the ability to synthesize different forms of genes and groups of genes, to inject them into an embryo, and to have them "take" and be expressed properly will no doubt be perfected. It has already been done with some success in dogs, fruit flies, and of course, bacteria. (Such manipulations are much simpler in plants, which explains the early successes in agriculture.) Probably within ten years from now it will be possible to engineer human designer children as easily as we now do with crops. Social constraints will of course prevent immediate application of such techniques in the United States and Europe, but the technology will be world-wide, on the internet, and scientists willing to undertake the work will not be hard to find. People will be able to select not only the gender of their baby, but its height, build, coloring, tendency to obesity, resistance to several mental diseases including depression and schizophrenia, immunity to hundreds of physical diseases, many aspects of intelligence and personal gifts such as musical and artistic talent, athletic prowess, mathematical and analytical ability, leadership qualities, even elements of character such as a tendency to be brave, honorable, or monogamous, and to have an adventurous spirit. We can even endow them with a long, long life, perhaps 200 years or more.

But even more amazing is the prospect of genetic medicine, and it is almost upon us already. A biopsy specimen of cancerous tissue will enable the culturing and DNA analysis of each individual malignancy so that a specific, unique "magic bullet" can be fashioned, the precisely perfect treatment down to the last atom. Antibiotic sensitivity will no longer be a problem, for the same reason. The hundreds of genetic diseases that we are heir to will likewise be treatable, and it will be possible to grow new limbs and organs that will never be rejected by the body.

This will all be easier than most of us now think, because a lot of growth is automatic, in the same way that many molecules and nanostructures have been shown to auto-assemble themselves, given the precursors. I was amazed to learn just a couple of weeks ago that this is already being done with urinary bladders-only in research dogs, so far, but humans are next. A one-centimeter square piece of bladder can be grown into a fully functional organ in only about six weeks, and when implanted back into the dog, blood vessels and even the nerves grow back, so that conscious control is restored! That was utterly unexpected. Imagine: no more inconvenient, smelly bags! Remember, this is just tissue culture, without any genetic engineering. Let me give some examples of genetic medicine that are being successfully practiced in lab animals and in humans right now, today.

In January, two research groups reported success in reversing hemophilia B in dogs, using the gene that codes for the clotting protein known as factor IX. They put it into disabled adenoviruses and injected them into the animals. Injection into leg muscle was not very efficient, increasing the concentration of factor IX by only 1.4 %, but it was sufficient to prevent most of the dogs' spon-taneous internal bleeding. Injection into the portal vein, which supplies the liver where production of factor IX occurs naturally, was much more effective. Both approaches seem to be permanent-all animals continue to do well after 18 months.

In an ironic twist on the notorious role of tobacco in producing tumors, scientists at a company in California have succeeded in inducing tobacco plants to mass-produce effective antigens against non-Hodgkin's lymphoma. It turns out that the tobacco mosaic virus is an excellent vector for getting foreign genes into the plants. Literally every cell becomes infected, the yield is phenomenal, and it takes only two or three weeks to produce a "crop" of the new protein. The researchers used biopsy material from a mouse B lymphocyte lymphoma to produce a fragment of the DNA that codes for its characteristic surface antibody, put it inside specially prepared viruses, and injected them into a tobacco plant. Within a week the plant was producing the antigen in every cell, and within a month it had produced enough new protein to test. When injected into the mouse with that lymphoma, the antigens from the tobacco plants induced the mouse's system to make antibodies that effectively targeted the lymphoma cells. Even more significantly, this vaccine protected other, healthy mice injected with the lymphoma cells. It worked like a charm on the first try.

People who require more than one cardiac bypass or balloon angioplasty are dreaded by thoracic surgeons, because they seldom fare well. Doctors in Boston have injected DNA coding for a piece of the gene called vascular endo-thelial growth factor, which directs blood vessel growth, into the damaged, blood-starved heart muscle of human patients who have had several bypass operations but are still doing poorly. After three months, six of the eleven patients were entirely free of angina, and the overall use of nitroglycerin tablets by all eleven combined fell from an average of 60 pills a week to just 2.5-another impressive success on the first try. And this involved nothing more than injecting the naked DNA directly into the heart muscle-no virus vector required.

Finally, there is hope for people afflicted with the frailty of old age-which is all of us, eventually. Researchers at the University of Pennsylvania placed DNA coding for "insulinlike growth factor 1," a growth hormone, into disabled viruses and then injected them directly into the muscle of one hind leg of young, middle-aged, and elderly mice. After a few months of sedentary life, the treated leg in the young mice had 15% more mass and strength than the control leg. The effect was even greater in the geriatric mice: they showed 19% more mass and 27% more power in the treated leg, thus preserving their physical condition at young adult levels. Another near bulls-eye on the first try! Not only does this give promise of a real fountain of youth, it should also be effective in other muscle tissue, such as the heart. The effect has been expressed only locally so far, so people would require many injections to cover all their muscles. Cardiac therapy would need fewer injections, but in any case, it would only have to be done once. This is fantastic! I'm ready to sign up for this treatment right now.

These are only the first tentative forays into the new realm of genetic medicine, but wholesale application is, in many cases, just an FDA ruling away. And that brings me to the second usage of my new word, nanoculture: the ability to culture these brave, new nano-products in molecular biology laboratories so quickly and easily will, I believe, create a new world culture-a sub-culture unique to our time, as illegal and lucrative as the drug subculture, as pervasive and furtive as the homosexual subculture, all because the U.S. Food and Drug Administration will try to control genetic medicine, and they will fail.

The FDA is still smarting from the Dietary Supplement Health and Education Act of 1994, which was enacted by Congress in response to a major grass-roots movement. The agency had attempted to control the marketing and sale of mega-vitamins and other "natural" drugs for years, until finally, the producers got organized. They prepared standardized protest letters and included them with the packages, which millions of people signed and mailed to their representatives in Washington. Congress responded by making this new law that classified all naturally-derived products as "food," thereby preventing any interference from the FDA for the sale of anything that is simply extracted and concentrated from any living organism, including human hormones and metabolites. "Anything that God makes cannot be prohibited," went the mantra. That's why it is now possible to buy things like DHEA and melatonin, which I take daily, without a prescription. The most the FDA can do is prevent them from making direct health claims. I guess promises that these dietary supplements "promote healthy skin" or "increase energy" or "help improve memory" don't count as real medical claims. Of course, the gullible public knows exactly what the producers want them to think such language really means, and the FDA is extremely unhappy about it.

I believe the new and upcoming genetic medicines will eventually be removed from the FDA's purview also, but by a different process and with a different denouement. Unlike simple natural extracts like vitamins and hormones, these new medicines will be too expensive for most people to buy, and a grass-roots approach will not work. Instead, a small cadre of wealthy people will be the vanguard, and they will get their way simply by threatening to withhold millions of dollars from politicians' election coffers. But before that, there will be a chaotic period of several years during which the FDA will attempt to criminalize the purchase and use of these unregistered and unapproved drugs. I believe one of the reasons they will fail is that they will be unable to find them and interdict them. Another is the personal power of wealth and influential people. Speaking of lymphoma, who would try to arrest Jacqueline Kennedy Onassis or King Hussein, who both died of that cancer?

Perhaps some of the early gene products will require refrigeration during transport and careful dispensing by physicians, but eventually many of them will be as stable as any other virus, and just as easy to "catch" as a cold. Even if they must be injected, syringes are not hard to get. But imagine a genetic drug that can be micro-encapsulated and simply sent through the mail like a letter and then taken into the body with a scratch-and-sniff or scrape-and-swallow exercise. FDA would never be able to control that kind of commerce. Purveyors will be on the internet; the word will get around (on the internet) that, for example, Dr. Wong in Singapore has a superior product; a surreptitious deal will be struck; Dr. Wong may ship the material to any of a thousand intermediate handlers anywhere in the world, who will relay the merchandise to its final destination. If you think this sounds a bit like "dealing drugs" such as cocaine and heroin, you have gotten my point. A new illegal drug culture will develop, exactly analogous to the lawlessness of the Prohibition era in the '30s and the Drug War in the present. There won't be goons with machine guns in the streets, but it will create a pervasive contempt for the law among the middle and upper classes that will be every bit as corrosive to the republic. I believe one of the fallouts of this dark, lawless nanoculture will be the crippling, if not the destruction, of the FDA-at least, its drug approval and enforcement activities.

I believe another fallout of the coming nanoculture is that the huge, multi-national chemical/drug companies-the ones that are now abandoning their core businesses and jumping on the bandwagon created by the promise of the Human Genome Project-will lose their investment. They will try to patent everything they can, but the Dr. Wongs of the world will ignore them. It doesn't take much of a capital investment to manufacture a batch of DNA made to order-much less than a million dollars today-and the cost of the sequencing and synthesis machines will go down like the prices of cameras and calculators. All of the intellectual property needed will be readily available over the internet, and there will be nothing to stop the thousands of small entrepreneurs scattered all over the globe.

It will be a strange time, with the most amazing and fabulous products being shipped via the most mundane and innocuous routes, like the Hope diamond was mailed to The Smithsonian Institution. It makes me think of the closing lines of Sidney Lanier's great poem:

"And now from the vast of the Lord will the waters of sleep
Roll in on the souls of men,
But who will reveal to our waking ken
The forms that swim and the shapes that creep
Under the waters of sleep?
And I would I could know what swimmeth below when the tide comes in
On the length and the breadth of the marvellous marshes of Glynn."

1999 by William H. Beauman

Return to PAPERS
Return to Main Menu